View in EDS

Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry.

Saved in:

Bibliographic Details
Title:	Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry.
Authors:	Máspero JF; Fundación CIDEA, Paraguay 2035, 3° Cuerpo 2° Subsuelo, C1121ABE, Ciudad Autónoma de Buenos Aires, Argentina. jorge.maspero@fundacioncidea.org.ar., Arnaout RK; King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia., Vargas-Ramírez L; Instituto Neumológico del Oriente, Bucaramanga, Colombia., Mobayed H; Hamad Medical Corporation, Doha, Qatar., Mahboub B; Rashid Hospital, Dubai, UAE., Irani C; Hôtel-Dieu de France Hospital, Beirut-Saint Joseph University, Beirut, Lebanon., Bar-Shai A; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Tel Aviv University, Tel Aviv, Israel., Koh MS; Singapore General Hospital, Singapore, Singapore., Chao J; Sanofi, Morristown, NJ, USA., Zaghloul S; Sanofi, Dubai, UAE., Kwah JH; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Dewhurst J; Sanofi, Reading, UK., Al-Ahmad MS; College of Medicine, Kuwait University, Kuwait City, Kuwait.; Al-Rashed Allergy Center, Ministry of Health, Kuwait City, Kuwait.
Source:	Advances in therapy [Adv Ther] 2026 Jun 10. Date of Electronic Publication: 2026 Jun 10.
Publication Type:	Journal Article
Journal Info:	Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1865-8652
DOI:	10.1007/s12325-026-03623-2